Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target entry describes a complex biological process rather than a single molecular entity, encompassing the coordinated actions of the innate and adaptive immune systems. It involves the detection of pathogen-associated molecular patterns (PAMPs) by pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs) and C-type lectin receptors, which triggers the uptake of antigens by professional antigen-presenting cells (APCs) [Janeway & Medzhitov, 2002]. Following uptake, antigens are processed and loaded onto Major Histocompatibility Complex (MHC) molecules for presentation to T-lymphocytes, a critical step for initiating adaptive immunity [Roche & Furuta, 2015]. This pathway is a primary focus for vaccine development, where adjuvants are used to target PRRs to enhance the efficiency of antigen presentation and the subsequent memory response [Koff et al., 2013]. Therapeutic modulation of this system is also explored in cancer immunotherapy to overcome tumor-induced immunosuppression by promoting robust dendritic cell activation [Brubaker et al., 2015]. Because it involves a complex cascade of signaling molecules and cellular interactions, it is not a single molecular entity but rather a coordinated biological pathway [Janeway & Medzhitov, 2002].
Activation of pattern-recognition receptors (PRRs) to stimulate antigen uptake, processing, and subsequent presentation on MHC molecules to activate T-cells.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate and adaptive immune system components via antigen presentation and pattern-recognition receptor–mediated uptake.